{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:10:40Z","timestamp":1793124640793,"version":"4.5.0"},"reference-count":437,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jconrel.2023.09.011","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:54:22Z","timestamp":1695300862000},"page":"728-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Gout therapeutics and drug delivery"],"prefix":"10.1016","volume":"362","author":[{"given":"Xiuju","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Sosnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Boucetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.09.011_bb0005","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0010","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1001\/jama.2021.19770","article-title":"What is gout?","volume":"326","author":"Yip","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0015","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1503\/cmaj.201392","article-title":"Gout","volume":"193","author":"Kwok","year":"2021","journal-title":"CMAJ."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13075-018-1612-1","article-title":"Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies","volume":"20","author":"Evans","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41467-021-27945-7","article-title":"Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia","volume":"13","author":"Sands","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0035","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","article-title":"Comorbidity clusters in people with gout: an observational cohort study with linked medical record review","volume":"57","author":"Bevis","year":"2018","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0040","doi-asserted-by":"crossref","first-page":"1045805","DOI":"10.3389\/fnut.2022.1045805","article-title":"Dietary intake of fructose increases purine de novo synthesis: A crucial mechanism for hyperuricemia","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Nutrition"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.33315","article-title":"Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study","volume":"64","author":"McAdams DeMarco","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/annrheumdis-2019-eular.804","article-title":"Occupational exposure to inorganic dust - A novel risk factor for incident gout?","volume":"78","author":"Sigurdardottir","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0060","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels","volume":"51","author":"Tin","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010166","article-title":"Gouty arthropathy: review of clinical manifestations and treatment, with emphasis on imaging","volume":"11","author":"Weaver","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of gout and hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0075","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1001\/jama.2021.19763","article-title":"Management of Gout","volume":"326","author":"Anderson","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","article-title":"Update on gout management: what is old and what is new","volume":"34","author":"Afinogenova","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cclet.2021.08.020","article-title":"Liposome-based delivery of biological drugs","volume":"33","author":"Magar","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.apsb.2021.08.009","article-title":"Pulmonary delivery of siRNA against acute lung injury\/acute respiratory distress syndrome","volume":"12","author":"Zoulikha","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0095","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/j.cclet.2021.03.085","article-title":"Cocrystallization-like strategy for the codelivery of hydrophobic and hydrophilic drugs in a single carrier material formulation","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","author":"Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","article-title":"Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases","volume":"165-166","author":"He","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0110","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.apsb.2020.12.018","article-title":"Biological drug and drug delivery-mediated immunotherapy","volume":"11","author":"Xiao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0115","series-title":"StatPearls; StatPearls Publishing Copyright \u00a9 2023","article-title":"Hyperuricosuria","author":"Kaur","year":"2023"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0120","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.semarthrit.2020.04.007","article-title":"The biology of urate","volume":"50","author":"Keenan","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","article-title":"Role of the intestinal tract in the elimination of uric acid","volume":"8","author":"Sorensen","year":"1965","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00296-021-05007-x","article-title":"Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development","volume":"42","author":"M\u00e9ndez-Salazar","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout","volume":"40","author":"Vitart","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux","volume":"13","author":"Bakhiya","year":"2003","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter hOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136678","article-title":"The role of ABCG2 in the pathogenesis of primary hyperuricemia and gout-an update","volume":"22","author":"Eckenstaler","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-022-00848-7","article-title":"Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia","author":"P\u00e1link\u00e1s","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0170","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2019-215521","article-title":"Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout","volume":"78","author":"Kawamura","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0180","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/art.41038","article-title":"Human cartilage homogenates influence the crystallization of monosodium urate and inflammatory response to monosodium urate crystals: a potential link between osteoarthritis and gout","volume":"71","author":"Chhana","year":"2019","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0185","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/art.41391","article-title":"Cholesterol and monosodium urate monohydrate crystals in synovial fluid from a patient with gout","volume":"72","author":"Bansal","year":"2020","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0190","article-title":"Lower temperatures exacerbate NLRP3 inflammasome activation by promoting monosodium urate crystallization","volume":"10","author":"Ahn","year":"2021","journal-title":"Caus. Gout. Cells"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0200","article-title":"Recent insights into the role of macrophages in acute gout","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0210","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1097\/RHU.0000000000001394","article-title":"Activation status of NLRP3 inflammasome in peripheral blood mononuclear cells from patients with gout flare","volume":"26","author":"Amezcua-Castillo","year":"2020","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105365","article-title":"Activation and function of NLRP3 inflammasome in bone and joint-related diseases","volume":"23","author":"Murakami","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.06.011","article-title":"Macrophages-regulating nanomedicines for sepsis therapy","volume":"34","author":"Deng","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0225","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","article-title":"AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages","volume":"75","author":"Wang","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091880","article-title":"Autoinflammatory features in gouty arthritis","volume":"10","author":"Galozzi","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0240","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/annrheumdis-2020-219796","article-title":"Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank","volume":"80","author":"Sandoval-Plata","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0245","article-title":"Neutrophil extracellular trap-borne elastase prevents inflammatory relapse in intercritical gout","author":"Liu","year":"2022","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0250","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2010.145821","article-title":"Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGF\u03b21, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3","volume":"70","author":"Chen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0255","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","article-title":"Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout","volume":"18","author":"Liu","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-014-0492-x","article-title":"The gouty tophus: a review","volume":"17","author":"Chhana","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0265","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s10067-022-06084-4","article-title":"Ocular manifestation in gout: an unusual presentation of gout","volume":"41","author":"Barranco-Trabi","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/bjh.13633","article-title":"Gouty tophi in the bone marrow","volume":"172","author":"Agarwaal","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00541376","article-title":"Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules","volume":"7","author":"Palmer","year":"1987","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0285","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/ard.2008.094201","article-title":"Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography","volume":"68","author":"Dalbeth","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0290","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/wrr.12973","article-title":"Gout-associated uric acid crystals induce tophi ulcerations and impair wound healing in a novel gouty ulcer model","volume":"30","author":"Bao","year":"2022","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0295","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/ard.2008.094201","article-title":"Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography","volume":"68","author":"Dalbeth","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0300","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/art.23488","article-title":"Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells","volume":"58","author":"Dalbeth","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3899\/jrheum.150738","article-title":"Path analysis identifies receptor activator of nuclear factor-\u03baB ligand, osteoprotegerin, and sclerostin as potential mediators of the tophus-bone erosion relationship in gout","volume":"43","author":"Chhana","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0310","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.semarthrit.2021.10.002","article-title":"Denosumab did not improve computerized tomography erosion scores when added to intensive urate-lowering therapy in gout: Results from a pilot randomized controlled trial","volume":"51","author":"Gaffo","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0315","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/annrheumdis-2013-205036","article-title":"Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial","volume":"73","author":"Dalbeth","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101719","article-title":"Treatment advances in gout","volume":"35","author":"Stamp","year":"2021","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11926-020-00967-8","article-title":"Something old, something new: the ACR gout treatment guideline and its evolution from 2012 to 2020","volume":"23","author":"Cohen","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0330","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/acem.14425","article-title":"Colchicine for acute gout","volume":"29","author":"Gottlieb","year":"2022","journal-title":"Acad. Emerg. Med. Off. J. Soc. Acad. Emerg. Med"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0335","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14740338.2017.1284199","article-title":"The safety of treatment options available for gout","volume":"16","author":"Schlesinger","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0340","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7861\/clinmedicine.13-4-400","article-title":"Treatment of hyperuricaemia and gout","volume":"13","author":"Roddy","year":"2013","journal-title":"Clin. Med. (London, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0345","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0350","first-page":"209","article-title":"Management of gout: update from the American college of rheumatology","volume":"104","author":"Dakkak","year":"2021","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0360","series-title":"In Evidence reviews for which people with gout should be offered a urate-lowering therapy: Gout: diagnosis and management: Evidence review E; National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2022.: London","author":"NICE Evidence Reviews Collection","year":"2022"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.925219","article-title":"Review of urate-lowering therapeutics: from the past to the future","volume":"13","author":"Jenkins","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0370","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.41063","article-title":"Effects of conventional uric acid-lowering therapy on monosodium urate crystal deposits","volume":"72","author":"Ellmann","year":"2020","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0375","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/art.40159","article-title":"Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in Patients with tophaceous gout: findings of a phase III clinical trial","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0380","series-title":"StatPearls; StatPearls Publishing Copyright \u00a9 2022","article-title":"Colchicine","author":"Sadiq","year":"2022"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0385","first-page":"Cd006190","article-title":"Colchicine for acute gout","volume":"8","author":"McKenzie","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/rheumatology\/keab303","article-title":"Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies","volume":"61","author":"Ahn","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0395","first-page":"Cd010120","article-title":"Non-steroidal anti-inflammatory drugs for acute gout","volume":"12","author":"van Durme","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0400","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26061576","article-title":"Lipid formulations and bioconjugation strategies for indomethacin therapeutic advances","volume":"26","author":"Gliszczy\u0144ska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036748","article-title":"Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0415","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prostaglandins.2018.10.005","article-title":"Variability in analgesic response to non-steroidal anti-inflammatory drugs","volume":"139","author":"Theken","year":"2018","journal-title":"Prostagland. Lipid. Mediat."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0420","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/M14-2070","article-title":"Oral prednisolone in the treatment of acute gout: a pragmatic, multicenter, double-blind, randomized trial","volume":"164","author":"Rainer","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0425","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1016\/j.cclet.2022.03.061","article-title":"Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease","volume":"33","author":"Sun","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0430","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"Prevalence of contraindications and prescription of pharmacologic therapies for gout","volume":"124","author":"Keenan","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0435","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0440","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10787-020-00753-z","article-title":"Effect of canakinumab on clinical and biochemical parameters in acute gouty arthritis: a meta-analysis","volume":"29","author":"Jena","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0445","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.41699","article-title":"A randomized, phase II study evaluating the efficacy and safety of anakinra in the treatment of gout flares","volume":"73","author":"Saag","year":"2021","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0450","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/RHU.0000000000001831","article-title":"Factors affecting response to anakinra in crystalline arthritis flares","volume":"28","author":"Ahmed","year":"2022","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","article-title":"Cytokine traps: multi-component, high-affinity blockers of cytokine action","volume":"9","author":"Economides","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0460","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000512178","article-title":"Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients","volume":"30","author":"Cicero","year":"2021","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0465","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40261-020-00941-3","article-title":"Long-term safety and effectiveness of the xanthine oxidoreductase inhibitor, topiroxostat in Japanese hyperuricemic patients with or without gout: A 54-week open-label, multicenter, post-marketing observational study","volume":"40","author":"Ishikawa","year":"2020","journal-title":"Clin. Drug Investigat."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0470","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0475","series-title":"Medical Genetics Summaries","article-title":"Allopurinol therapy and HLA-B*58:01 genotype","author":"Dean","year":"2012"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0480","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s10067-020-05161-w","article-title":"Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study","volume":"39","author":"Kim","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0485","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s10067-020-05079-3","article-title":"Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review","volume":"39","author":"Hu","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0490","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"Sircar","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0495","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/np8007123","article-title":"Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin","volume":"72","author":"Pauff","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0500","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cpt.2630","article-title":"Blockade of organic anion transport in humans after treatment with the drug probenecid leads to major metabolic alterations in plasma and urine","volume":"112","author":"Granados","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0505","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4062\/biomolther.2019.047","article-title":"Inhibitory effect of probenecid on osteoclast formation via JNK, ROS and COX-2","volume":"28","author":"Cheng","year":"2020","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0510","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1093\/ndt\/gfr060","article-title":"HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency","volume":"26","author":"Jung","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060899","article-title":"Modulation of urate transport by drugs","volume":"13","author":"T\u00e1trai","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0520","article-title":"Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present)","author":"Shi","year":"2023","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40360-020-0386-7","article-title":"Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study","volume":"21","author":"Alghamdi","year":"2020","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-019-01811-9","article-title":"Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia","volume":"24","author":"Kuriyama","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40259-015-0116-7","article-title":"Enzymes approved for human therapy: indications, mechanisms and adverse effects","volume":"29","author":"Baldo","year":"2015","journal-title":"BioDrugs : Clin. Immunotherap. Biopharm. Gene Therapy"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0540","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/14712598.2020.1787980","article-title":"Enzyme therapy: a forerunner in catalyzing a healthy society?","volume":"20","author":"Datta","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0545","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.semarthrit.2020.04.011","article-title":"Pegloticase treatment of chronic refractory gout: update on efficacy and safety","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0550","first-page":"1006","article-title":"Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels","volume":"40","author":"Keenan","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0555","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3899\/jrheum.190161","article-title":"Dissociation between clinical benefit and persistent urate lowering in patients with chronic refractory gout treated with pegloticase","volume":"47","author":"Pillinger","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0560","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041167","article-title":"Real-world patterns of pegloticase use for treatment of gout: descriptive multidatabase cohort study","volume":"10","author":"Chen","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0565","article-title":"Oral treatment with an engineered uricase, ALLN-346, reduces hyperuricemia, and uricosuria in urate oxidase-deficient mice","volume":"7","author":"Pierzynowska","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0570","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000459146","article-title":"Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity","volume":"26","author":"Nishimura","year":"1981","journal-title":"Enzyme"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0575","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1039\/D0FO01774D","article-title":"Discovery of a novel rice-derived peptide with significant anti-gout potency","volume":"11","author":"Liu","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0580","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1142\/S0192415X22500951","article-title":"Berberine attenuates hyperuricemia by regulating urate transporters and gut microbiota","volume":"50","author":"Shan","year":"2022","journal-title":"Am. J. Chinese Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0585","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13813455.2019.1610779","article-title":"Natural products for the management of hyperuricaemia and gout: a review","volume":"127","author":"El-Tantawy","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0590","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/JLB.3CE1018-384R","article-title":"Ancient herbal component may be a novel therapeutic for gouty arthritis","volume":"105","author":"Chen","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0595","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijbiomac.2018.11.077","article-title":"Anti-hyperuricemic and anti-gouty arthritis activities of polysaccharide purified from Lonicera japonica in model rats","volume":"123","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0600","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/19390211.2020.1757798","article-title":"Effect of curcumin on serum urate in asymptomatic hyperuricemia: a randomized placebo-controlled trial","volume":"18","author":"Bupparenoo","year":"2021","journal-title":"J. Dietary Supplements"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0605","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13063-022-06188-x","article-title":"Oral Huzhang granules for the treatment of acute gouty arthritis: protocol for a double-blind, randomized, controlled trial","volume":"23","author":"Zhou","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0610","doi-asserted-by":"crossref","first-page":"e11468","DOI":"10.7717\/peerj.11468","article-title":"Older age and diclofenac are associated with increased risk of upper gastrointestinal bleeding in gout patients","volume":"9","author":"Wan Ghazali","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0615","first-page":"Cd005521","article-title":"Systemic corticosteroids for acute gout","volume":"2008","author":"Janssens","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0620","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/1744666X.2014.880653","article-title":"Canakinumab for gout: a specific, patient-profiled indication","volume":"10","author":"Perez-Ruiz","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0625","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/ket114","article-title":"Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial","volume":"52","author":"Mitha","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0630","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42358-019-0080-x","article-title":"Benzbromarone in the treatment of gout","volume":"59","author":"Azevedo","year":"2019","journal-title":"Adv. Rheumatol. (London, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0635","first-page":"Cd010457","article-title":"Uricosuric medications for chronic gout","author":"Kydd","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0640","first-page":"374","article-title":"Lesinurad (Zurampic) for Gout","volume":"97","author":"On","year":"2018","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0645","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/14656566.2021.1918102","article-title":"Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout","volume":"22","author":"Ishikawa","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0650","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/art.39684","article-title":"A randomized, double-blind, active- and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout","volume":"68","author":"Poiley","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0655","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2017.20189","article-title":"Lesinurad\/allopurinol (Duzallo) for gout-associated hyperuricemia","volume":"319","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0660","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd3349","article-title":"Pegloticase","volume":"10","author":"Schlesinger","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0665","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1345\/aph.1C336","article-title":"Rasburicase for the treatment and prevention of hyperuricemia","volume":"37","author":"Yim","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0670","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2020.09.009","article-title":"Effect of intensive urate lowering with combined verinurad and febuxostat on albuminuria in patients with type 2 diabetes: a randomized trial","volume":"77","author":"Stack","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0675","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fimmu.2020.00969","article-title":"Development of ImmTOR tolerogenic nanoparticles for the mitigation of anti-drug antibodies","volume":"11","author":"Kishimoto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0680","doi-asserted-by":"crossref","DOI":"10.1007\/s40744-023-00546-0","article-title":"Phase 2 dose-finding study in patients with gout using SEL-212, a novel PEGylated uricase (SEL-037) combined with tolerogenic nanoparticles (SEL-110)","author":"Kivitz","year":"2023","journal-title":"Rheumatol. Therapy"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0685","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.semarthrit.2021.01.005","article-title":"The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review","volume":"51","author":"Keenan","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0690","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13075-022-02979-4","article-title":"Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial","volume":"24","author":"Botson","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0695","first-page":"1976","article-title":"URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers","volume":"58","author":"Lee","year":"2019","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0700","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1093\/rheumatology\/keab198","article-title":"Efficacy and safety of a selective URAT1 inhibitor SHR4640 in Chinese subjects with hyperuricaemia: a randomized controlled phase II study","volume":"60","author":"Lin","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/art.42447","article-title":"Serum urate-lowering efficacy and safety of tigulixostat in gout patients with hyperuricemia: a randomized, double-blind, placebo-controlled, dose-finding trial","author":"Terkeltaub","year":"2023","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0710","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0715","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3904\/kjim.2021.363","article-title":"Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J. Int. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0720","article-title":"Lipid carriers for mRNA delivery","author":"Zhang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0730","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2011.12.034","article-title":"Altering the immune response with lipid-based nanoparticles","volume":"161","author":"Landesman-Milo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0735","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2217\/nnm-2021-0335","article-title":"Transfersomes as alternative topical nanodosage forms for the treatment of skin disorders","volume":"16","author":"Oyarzun","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0740","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fphar.2015.00219","article-title":"Lipid-based nano-delivery systems for skin delivery of drugs and bioactives","volume":"6","author":"Hua","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0745","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1208\/s12249-019-1476-y","article-title":"Quality by design approach for the development of self-emulsifying systems for oral delivery of febuxostat: pharmacokinetic and pharmacodynamic evaluation","volume":"20","author":"Rangaraj","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0750","first-page":"817","article-title":"Liposomes and liposome-like nanoparticles: from anti-fungal infection to the COVID-19 pandemic treatment","volume":"17","author":"He","year":"2022","journal-title":"Asian J. Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0755","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1016\/j.cclet.2022.04.033","article-title":"Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes","volume":"33","author":"Boafo","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0765","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/D0NH00605J","article-title":"Targeted liposomal drug delivery: a nanoscience and biophysical perspective","volume":"6","author":"Liu","year":"2021","journal-title":"Nanoscale Horizons"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1450","article-title":"Stimuli-responsive liposomes for drug delivery. Wiley interdisciplinary reviews","volume":"9","author":"Lee","year":"2017","journal-title":"Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0775","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4155\/tde-2018-0035","article-title":"Long circulating liposomes: challenges and opportunities","volume":"9","author":"Deodhar","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0780","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cis.2014.12.001","article-title":"Aphron applications--a review of recent and current research","volume":"216","author":"Molaei","year":"2015","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0785","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.nano.2016.02.010","article-title":"Nanocapsule assemblies as effective enzyme delivery systems against hyperuricemia","volume":"12","author":"Xiong","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0790","doi-asserted-by":"crossref","first-page":"15222","DOI":"10.1039\/D0NR02651D","article-title":"Biomimetic polysaccharide-cloaked lipidic nanovesicles\/microassemblies for improving the enzymatic activity and prolonging the action time for hyperuricemia treatment","volume":"12","author":"Yang","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0795","doi-asserted-by":"crossref","first-page":"1033520","DOI":"10.3389\/fphar.2022.1033520","article-title":"Protein phosphatase 2A regulates xanthine oxidase-derived ROS production in macrophages and influx of inflammatory monocytes in a murine gout model","volume":"13","author":"Elsayed","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0800","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acs.bioconjchem.9b00051","article-title":"Phospholipidic colchicinoids as promising prodrugs incorporated into enzyme-responsive liposomes: chemical, biophysical, and enzymological aspects","volume":"30","author":"Shchegravina","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031034","article-title":"Liposomal formulation of a PLA2-sensitive phospholipid-allocolchicinoid conjugate: stability and activity studies in vitro","volume":"23","author":"Kobanenko","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0810","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1016\/j.cclet.2022.01.083","article-title":"Liposome-based anchoring and core-encapsulation for combinatorial cancer therapy","volume":"33","author":"Xiao","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0815","series-title":"Medical Genetics Summaries","article-title":"Pegloticase therapy and G6PD genotype","author":"Dean","year":"2012"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0820","article-title":"Rasburicase-induced methemoglobinemia","volume":"13","author":"Ahmed","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0825","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nnano.2012.264","article-title":"Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication","volume":"8","author":"Liu","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0830","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201707443","article-title":"A hepatocyte-mimicking antidote for alcohol intoxication","volume":"30","author":"Xu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0835","article-title":"Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changes","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0840","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.09.006","article-title":"Novel lipidic and bienzymatic nanosomes for efficient delivery and enhanced bioactivity of catalase","volume":"532","author":"Li","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0845","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120271","article-title":"Sterilization methods of liposomes: drawbacks of conventional methods and perspectives","volume":"597","author":"Delma","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0855","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0860","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1038\/s41467-022-34750-3","article-title":"Microfluidic vortex focusing for high throughput synthesis of size-tunable liposomes","volume":"13","author":"Han","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0865","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0870","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903156","article-title":"On the structure of solid lipid nanoparticles","volume":"15","author":"Pink","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0875","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0880","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17425247.2020.1727883","article-title":"SLN and NLC for topical, dermal, and transdermal drug delivery","volume":"17","author":"Souto","year":"2020","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0885","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0890","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10717544.2014.898110","article-title":"Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration","volume":"22","author":"Gaba","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0895","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17425255.2019.1621289","article-title":"Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs","volume":"15","author":"Banerjee","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0900","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijpharm.2018.08.028","article-title":"Enhanced oral bioavailability and anti-gout activity of [6]-shogaol-loaded solid lipid nanoparticles","volume":"550","author":"Wang","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0905","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4274\/tjps.galenos.2019.32656","article-title":"Design and optimization of febuxostat-loaded nano lipid carriers using full factorial design","volume":"18","author":"Bhatt","year":"2021","journal-title":"Turkish J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0910","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jddst.2017.08.013","article-title":"Fabrication and in-vivo evaluation of lipid nanocarriers based transdermal patch of colchicine","volume":"41","author":"Joshi","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0915","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijbiomac.2017.05.132","article-title":"Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone","volume":"103","author":"Tan","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0920","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijbiomac.2018.03.117","article-title":"Nanostructured lipid carrier-based pH and temperature dual-responsive hydrogel composed of carboxymethyl chitosan and poloxamer for drug delivery","volume":"114","author":"Yu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0925","doi-asserted-by":"crossref","DOI":"10.1002\/app.46004","article-title":"Solid lipid nanoparticles loaded thermoresponsive pluronic-xanthan gum hydrogel as a transdermal delivery system","volume":"135","author":"Lee","year":"2018","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0930","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","article-title":"Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs","volume":"66","author":"Chiappetta","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0935","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.05.032","article-title":"Solid lipid nanoparticles for hydrophilic drugs","volume":"335","author":"Mirchandani","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0940","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3109\/02652048.2010.513456","article-title":"Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies","volume":"27","author":"Liu","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051543","article-title":"Perspectives and prospective on solid lipid nanoparticles as drug delivery systems","volume":"27","author":"Madkhali","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0950","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0955","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","article-title":"Solid lipid nanoparticles: a review on recent perspectives and patents","volume":"30","author":"Paliwal","year":"2020","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0960","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1208\/s12249-021-02166-9","article-title":"Transfersomes: a revolutionary nanosystem for efficient transdermal drug delivery","volume":"23","author":"Akram","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0965","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.cclet.2018.10.037","article-title":"Nano-formulations for transdermal drug delivery: a review","volume":"29","author":"Zhou","year":"2018","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0970","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0168-3659(95)00056-E","article-title":"Transdermal drug carriers - basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides","volume":"36","author":"Cevc","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0975","doi-asserted-by":"crossref","first-page":"113450","DOI":"10.1016\/j.biopha.2022.113450","article-title":"Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer's disease: In vitro, in vivo, and ex vivo evaluations","volume":"153","author":"Nojoki","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0980","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090855","article-title":"Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery","volume":"12","author":"Opatha","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb0985","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1080\/03639045.2020.1788069","article-title":"Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation","volume":"46","author":"Dudhipala","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0990","doi-asserted-by":"crossref","first-page":"110929","DOI":"10.1016\/j.msec.2020.110929","article-title":"Monoterpenes-containing PEGylated transfersomes for enhancing joint cavity drug delivery evidenced by CLSM and double-sited microdialysis","volume":"113","author":"Zheng","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2023.09.011_bb0995","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2217\/nnm-2020-0316","article-title":"Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-\u03ba\u03b2 pathway","volume":"16","author":"Sana","year":"2021","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1000","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/10717544.2022.2053761","article-title":"Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin","volume":"29","author":"Yuan","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1005","doi-asserted-by":"crossref","first-page":"8170318","DOI":"10.1155\/2022\/8170318","article-title":"Development and in vitro\/ex vivo evaluation of lecithin-based deformable transfersomes and transfersome-based gels for combined dermal delivery of meloxicam and dexamethasone","volume":"2022","author":"Khan","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jddst.2018.10.036","article-title":"Flexible nano-sized lipid vesicles for the transdermal delivery of colchicine; in vitro\/in vivo investigation","volume":"49","author":"El-Feky","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/1574885515666200120124214","article-title":"Allopurinol loaded transferosomes for alleviation of symptomatic after-effects of gout: an account of pharmaceutical implications","volume":"15","author":"Tiwari","year":"2020","journal-title":"Curr. Drug Therapy"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1020","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3899\/jrheum.130192","article-title":"A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel","volume":"40","author":"Rother","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/ket133","article-title":"A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis","volume":"52","author":"Conaghan","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118817","article-title":"Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale","volume":"573","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1567201815666180116091604","article-title":"Ethosomes as novel vesicular carrier: an overview of the principle, preparation and its applications","volume":"15","author":"Das","year":"2018","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11095-021-03053-5","article-title":"Ethosomes as nanocarriers for the development of skin delivery formulations","volume":"38","author":"Paiva-Santos","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.02.021","article-title":"Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes","volume":"298","author":"L\u00f3pez-Pinto","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jddst.2019.05.048","article-title":"Formulation development of ethosomes containing indomethacin for transdermal delivery","volume":"52","author":"Sakdiset","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119936","article-title":"Development of curcumin-loaded composite phospholipid ethosomes for enhanced skin permeability and vesicle stability","volume":"592","author":"Li","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/10717544.2018.1559258","article-title":"Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome","volume":"26","author":"Zhang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1065","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3109\/03639045.2015.1107095","article-title":"Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids","volume":"42","author":"Yi","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1070","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1208\/s12249-010-9509-6","article-title":"Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH-gradient method","volume":"11","author":"Zhou","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","article-title":"A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation","volume":"92","author":"Song","year":"2012","journal-title":"Colloids Surf. B-Biointerf."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1080","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/DDDT.S158018","article-title":"Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation","volume":"12","author":"Abdulbaqi","year":"2018","journal-title":"Drug Design Develop. Therapy"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1085","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S86186","article-title":"Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes","volume":"10","author":"Ascenso","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315112","article-title":"Ex vivo evaluation of ethosomes and transethosomes applied on human skin: a comparative study","volume":"23","author":"Esposito","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1095","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/1567201817666200826093102","article-title":"Recent developments in the principles, modification and application prospects of functionalized ethosomes for topical delivery","volume":"18","author":"Lu","year":"2021","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1105","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2147\/IJN.S105016","article-title":"Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials","volume":"11","author":"Abdulbaqi","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1110","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1080\/10717544.2022.2081739","article-title":"Pentapeptide modified ethosomes for enhanced skin retention and topical efficacy activity of indomethacin","volume":"29","author":"Niu","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1115","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","article-title":"Niosomes: a controlled and novel drug delivery system","volume":"34","author":"Rajera","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","article-title":"Nonionic surfactant vesicular systems for effective drug delivery\u2014an overview","volume":"1","author":"Kumar","year":"2011","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/08982104.2019.1652646","article-title":"Preparation and evaluation of transdermal naproxen niosomes: formulation optimization to preclinical anti-inflammatory assessment on murine model","volume":"30","author":"Mohanty","year":"2020","journal-title":"J. Liposome. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jddst.2017.04.020","article-title":"Transdermal potential and anti-gout efficacy of Febuxostat from niosomal gel","volume":"39","author":"Singh","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/1061186X.2021.1941060","article-title":"Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)","volume":"30","author":"Akbari","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1140","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.2147\/IJN.S382192","article-title":"Nanovesicles-mediated drug delivery for oral bioavailability enhancement","volume":"17","author":"Ren","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/08982104.2016.1174943","article-title":"Oral delivery of allopurinol niosomes in treatment of gout in animal model","volume":"27","author":"Singh","year":"2017","journal-title":"J. Liposome. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1150","doi-asserted-by":"crossref","first-page":"13665","DOI":"10.1021\/acsami.2c02182","article-title":"Nanodiamond integration into niosomes as an emerging and efficient gene therapy nanoplatform for central nervous system diseases","volume":"14","author":"Al Qtaish","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1155","doi-asserted-by":"crossref","first-page":"121878","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17425247.2020.1822322","article-title":"Emerging potential of niosomes in ocular delivery","volume":"18","author":"Verma","year":"2021","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179668","article-title":"Current advances in specialised niosomal drug delivery: manufacture, characterization and drug delivery applications","volume":"23","author":"Witika","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.bioconjchem.6b00569","article-title":"Biointerfacing and applications of cell membrane-coated nanoparticles","volume":"28","author":"Kroll","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1180","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.2147\/DDDT.S282368","article-title":"A review of biomimetic nanoparticle drug delivery systems based on cell membranes","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.apsb.2017.12.002","article-title":"Biomimetic nanoparticles for inflammation targeting","volume":"8","author":"Jin","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1190","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1195","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2022.09.012","article-title":"Stem cell membrane-coated abiotic nanomaterials for biomedical applications","volume":"351","author":"Ferreira-Faria","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1205","article-title":"White blood cell membrane-coated nanoparticles: recent development and medical applications","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1210","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1021\/acs.nanolett.0c01654","article-title":"Multimodal enzyme delivery and therapy enabled by cell membrane-coated metal-organic framework nanoparticles","volume":"20","author":"Zhuang","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1215","doi-asserted-by":"crossref","DOI":"10.3390\/nano11071759","article-title":"Enhancement of thermostability of aspergillus flavus urate oxidase by immobilization on the Ni-based magnetic metal-organic framework","volume":"11","author":"Motamedi","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1220","article-title":"Membrane cholesterol depletion enhances enzymatic activity of cell-membrane-coated metal-organic-framework nanoparticles","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/anie.201508339","article-title":"Systemically injectable enzyme-loaded polyion complex vesicles as in vivo nanoreactors functioning in tumors","volume":"55","author":"Anraku","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biotechadv.2018.11.007","article-title":"Tools and strategies for constructing cell-free enzyme pathways","volume":"37","author":"Petroll","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1235","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tibtech.2019.07.010","article-title":"Multienzymatic nanoassemblies: recent progress and applications","volume":"38","author":"Giannakopoulou","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1240","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202103645","article-title":"A novel cascade nanoreactor integrating two-dimensional Pd-Ru nanozyme, uricase and red blood cell membrane for highly efficient hyperuricemia treatment","volume":"17","author":"Ming","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal MicroRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genom. Proteom. Bioinformat."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102511","article-title":"Exosomes: effectual players in rheumatoid arthritis","volume":"19","author":"Tavasolian","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1255","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-020-00675-6","article-title":"Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis","volume":"18","author":"Yan","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1260","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","article-title":"Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation","volume":"15","author":"Chugh","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2020033111","article-title":"Self-emulsifying drug delivery system (SEDDS): an emerging dosage form to improve the bioavailability of poorly absorbed drugs","volume":"37","author":"Singh","year":"2020","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2019.01.008","article-title":"Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs","volume":"142","author":"Vithani","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1275","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.molliq.2017.08.002","article-title":"Development of dual drug loaded solid self microemulsifying drug delivery system: exploring interfacial interactions using QbD coupled risk based approach","volume":"242","author":"Vohra","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1280","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/jsfa.11542","article-title":"Enhanced oral bioavailability and anti-hyperuricemic activity of liquiritin via a self-nanoemulsifying drug delivery system","volume":"102","author":"Wei","year":"2022","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1285","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/10717544.2021.1927247","article-title":"Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films","volume":"28","author":"Habib","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1290","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060534","article-title":"Investigating the potential of transmucosal delivery of febuxostat from oral lyophilized tablets loaded with a self-nanoemulsifying delivery system","volume":"12","author":"Al-Amodi","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1295","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/10837450.2019.1700520","article-title":"Development of an optimized febuxostat self-nanoemulsified loaded transdermal film: in-vitro, ex-vivo and in-vivo evaluation","volume":"25","author":"Alhakamy","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1300","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/03639045.2017.1342654","article-title":"Review and analysis of FDA approved drugs using lipid-based formulations","volume":"43","author":"Savla","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1305","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.apsb.2021.03.025","article-title":"In vitro and in vivo correlation for lipid-based formulations: current status and future perspectives","volume":"11","author":"Huang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/2211738508666200811104240","article-title":"Self-emulsifying drug delivery system improve oral bioavailability: role of excipients and physico-chemical characterization","volume":"8","author":"Zhu","year":"2020","journal-title":"Pharmaceut. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1315","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/10837450.2022.2107014","article-title":"An overview of polyallylamine applications in gene delivery","volume":"27","author":"Gholami","year":"2022","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1320","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jconrel.2022.05.054","article-title":"Polymer nanotherapeutics: a versatile platform for effective rheumatoid arthritis therapy","volume":"348","author":"Nooreen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1325","article-title":"Stimuli-responsive poly(aspartamide) derivatives and their applications as drug carriers","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1330","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081298","article-title":"Thermostable and long-circulating albumin-conjugated arthrobacter globiformis urate oxidase","volume":"13","author":"Yang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1335","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1340","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.msec.2017.12.036","article-title":"Recent advances of PLGA micro\/nanoparticles for the delivery of biomacromolecular therapeutics","volume":"92","author":"Ding","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1345","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26102846","article-title":"Stereocomplex polylactide for drug delivery and biomedical applications: a review","volume":"26","author":"Im","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1350","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.952675","article-title":"Physically stimulus-responsive nanoparticles for therapy and diagnosis","volume":"10","author":"Farjadian","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1355","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2174\/1381612827666211208150210","article-title":"Stimuli-responsive polymeric nanosystems for therapeutic applications","volume":"28","author":"Handa","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1360","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.2147\/IJN.S231477","article-title":"Biomedical applications of multifunctional polymeric nanocarriers: a review of current literature","volume":"15","author":"Karabasz","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1365","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.chempr.2018.07.002","article-title":"Multi-stimuli-responsive polymer particles, films, and hydrogels for drug delivery","volume":"4","author":"Fu","year":"2018","journal-title":"Chem"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1370","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800917","article-title":"pH-responsive polymer nanoparticles for drug delivery","volume":"40","author":"Deirram","year":"2019","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1375","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.drudis.2020.06.028","article-title":"Polymer-drug conjugates: recent advances and future perspectives","volume":"25","author":"Thakor","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1380","doi-asserted-by":"crossref","first-page":"46118","DOI":"10.1021\/acsomega.2c04071","article-title":"PASylated urate oxidase enzyme: enhancing biocatalytic activity, physicochemical properties, and plasma half-life","volume":"7","author":"Najjari","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1385","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/acs.molpharmaceut.1c00231","article-title":"Multivalent albumin-neonatal Fc receptor interactions mediate a prominent extension of the serum half-life of a therapeutic protein","volume":"18","author":"Yang","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1390","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2020.01.034","article-title":"Intramolecular distance in the conjugate of urate oxidase and fatty acid governs FcRn binding and serum half-life in vivo","volume":"321","author":"Cho","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1395","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.cclet.2020.07.027","article-title":"Circumvent PEGylation dilemma by implementing matrix metalloproteinase-responsive chemistry for promoted tumor gene therapy","volume":"31","author":"Wang","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1400","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2012.03.057","article-title":"Characterization, efficacy, pharmacokinetics, and biodistribution of 5 kDa mPEG modified tetrameric canine uricase variant","volume":"430","author":"Zhang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1405","series-title":"StatPearls; StatPearls Publishing Copyright \u00a9 2022","article-title":"Pegloticase","author":"Padda","year":"2022"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1410","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"Ganson","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1415","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12247-016-9251-z","article-title":"Production and optimization of site-specific monoPEGylated uricase conjugates using mPEG-maleimide through RP-HPLC methodology","volume":"11","author":"Nanda","year":"2016","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1420","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11095-017-2167-6","article-title":"A trivalent enzymatic system for uricolytic therapy of HPRT deficiency and lesch-nyhan disease","volume":"34","author":"Ronda","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1425","series-title":"Proceedings of the International Conference on Recent Trends in Engineering and Material Sciences (ICEMS), Jaipur, INDIA, Mar 17-19","first-page":"10494","article-title":"Solid Phase PEGylation of Uricase","author":"Nanda","year":"2016"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1430","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1435","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1440","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molimm.2013.07.014","article-title":"Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins","volume":"57","author":"Saifer","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1445","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/acs.biomac.7b00443","article-title":"Effect of molecular architecture on cell interactions and stealth properties of PEG","volume":"18","author":"Ozer","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1450","first-page":"e2103672","article-title":"Polyethylene glycol-like brush polymer conjugate of a protein drug does not induce an antipolymer immune response and has enhanced pharmacokinetics than its polyethylene glycol counterpart","volume":"9","author":"Ozer","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1455","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nantod.2016.05.006","article-title":"Chemical conjugation of zwitterionic polymers protects immunogenic enzyme and preserves bioactivity without polymer-specific antibody response","volume":"11","author":"Liu","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1460","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jconrel.2021.08.051","article-title":"High MW polyethylene glycol prolongs circulation of pegloticase in mice with anti-PEG antibodies","volume":"338","author":"Talkington","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1465","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jconrel.2022.01.022","article-title":"A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes","volume":"343","author":"Talkington","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1470","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2018.06.002","article-title":"A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse","volume":"284","author":"McSweeney","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1475","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1480","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cclet.2020.11.029","article-title":"An overview of polymeric nanomicelles in clinical trials and on the market","volume":"32","author":"Zheng","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1485","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/IJN.S158585","article-title":"Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1490","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/aps.2016.126","article-title":"Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo","volume":"38","author":"Zeng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1495","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1080\/03639045.2020.1811302","article-title":"Antihyperuricemic efficacy of Scopoletin-loaded Soluplus micelles in yeast extract\/potassium oxonate-induced hyperuricemic mice","volume":"46","author":"Zeng","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1500","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02652048.2022.2096138","article-title":"Pinocembrin polymeric micellar drug delivery system: preparation, characterisation and anti-hyperuricemic activity evaluation","volume":"39","author":"Rong","year":"2022","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1505","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114463","article-title":"The in vivo fate of polymeric micelles","volume":"188","author":"Cai","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1510","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2016.12.027","article-title":"pH-sensitive polymeric micelles for targeted delivery to inflamed joints","volume":"246","author":"Li","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1515","doi-asserted-by":"crossref","first-page":"21076","DOI":"10.1021\/acsami.1c04953","article-title":"Dual-stimuli responsive polymeric micelles for the effective treatment of rheumatoid arthritis","volume":"13","author":"He","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1520","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.apsb.2021.04.010","article-title":"Delivery strategies of amphotericin B for invasive fungal infections","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1525","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cclet.2020.11.048","article-title":"Nanotechnology for diagnosis and therapy of rheumatoid arthritis: evolution towards theranostic approaches","volume":"32","author":"Zhao","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1530","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1653","article-title":"Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications","volume":"12","author":"Sun","year":"2020","journal-title":"Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1535","doi-asserted-by":"crossref","first-page":"21648","DOI":"10.1002\/anie.202008413","article-title":"A smart theranostic nanocapsule for spatiotemporally programmable photo-gene therapy","volume":"59","author":"Gong","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1540","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2017.03.019","article-title":"Nanocapsules of therapeutic proteins with enhanced stability and long blood circulation for hyperuricemia management","volume":"255","author":"Zhang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1545","article-title":"Spatial confined synergistic enzymes with enhanced uricolytic performance and reduced toxicity for effective gout treatment","volume":"14","author":"Zhang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1550","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1039\/C6CS00632A","article-title":"Colloidal capsules: nano- and microcapsules with colloidal particle shells","volume":"46","author":"Bollhorst","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1555","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1002\/anie.201402825","article-title":"Simple but precise engineering of functional nanocapsules through nanoprecipitation","volume":"53","author":"Yan","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1560","doi-asserted-by":"crossref","first-page":"26357","DOI":"10.1002\/anie.202110829","article-title":"Versatile polymer nanocapsules via redox competition","volume":"60","author":"Zhou","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1565","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.addr.2010.07.011","article-title":"Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells","volume":"62","author":"Dolman","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1570","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1208\/s12249-020-01695-z","article-title":"Formulation, optimization, and evaluation of allopurinol-loaded bovine serum albumin nanoparticles for targeting kidney in management of hyperuricemic nephrolithiasis: formulation, optimization, and evaluation of ABNPs for kidney targeting","volume":"21","author":"Kandav","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1575","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1166\/jbn.2021.3168","article-title":"Bmk9 and uricase nanoparticle complex for the treatment of gouty arthritis and uric acid nephropathy","volume":"17","author":"Han","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1580","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201800703","article-title":"Disease-triggered drug release effectively prevents acute inflammatory flare-ups, achieving reduced dosing","volume":"14","author":"Stubelius","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1585","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1021\/acs.chemrev.6b00532","article-title":"Acetalated dextran: a tunable and acid-labile biopolymer with facile synthesis and a range of applications","volume":"117","author":"Bachelder","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1590","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10856-022-06700-4","article-title":"Polymeric nanofibers for drug delivery applications: a recent review","volume":"33","author":"Duan","year":"2022","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1595","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101979","article-title":"Expanding the repertoire of electrospinning: new and emerging biopolymers, techniques, and applications","volume":"11","author":"Madruga","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1600","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.apsb.2020.11.010","article-title":"Enzyme-instructed hybrid nanogel\/nanofiber oligopeptide hydrogel for localized protein delivery","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1605","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2018.05.001","article-title":"Electrospinning: an enabling nanotechnology platform for drug delivery and regenerative medicine","volume":"132","author":"Chen","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1610","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158581","article-title":"Nanofiber carriers of therapeutic load: current trends","volume":"23","author":"Jarak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1615","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901287","article-title":"Electrospinning piezoelectric fibers for biocompatible devices","volume":"9","author":"Azimi","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1620","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/mabi.201600123","article-title":"A luteolin-loaded electrospun fibrous implantable device for potential therapy of gout attacks","volume":"16","author":"Wang","year":"2016","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1625","doi-asserted-by":"crossref","first-page":"39004","DOI":"10.1039\/D1RA07424E","article-title":"Zein as a versatile biopolymer: different shapes for different biomedical applications","volume":"11","author":"Tortorella","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1630","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.foodhyd.2019.04.004","article-title":"Encapsulation of allopurinol by glucose cross-linked gelatin\/zein nanofibers: characterization and release behavior","volume":"94","author":"Deng","year":"2019","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1635","doi-asserted-by":"crossref","first-page":"45673","DOI":"10.1021\/acsami.0c12410","article-title":"Advances in functional polymer nanofibers: from spinning fabrication techniques to recent biomedical applications","volume":"12","author":"Dos Santos","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1640","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116477","article-title":"Electrospun triaxial nanofibers with middle blank cellulose acetate layers for accurate dual-stage drug release","volume":"243","author":"Yang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1645","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1002\/anie.200900441","article-title":"Nanogels as pharmaceutical carriers: finite networks of infinite capabilities","volume":"48","author":"Kabanov","year":"2009","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1650","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/13813455.2019.1702702","article-title":"Appraisal of anti-gout potential of colchicine-loaded chitosan nanoparticle gel in uric acid-induced gout animal model","volume":"128","author":"Parashar","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1655","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcis.2022.04.030","article-title":"Controlled synthesis of PEGylated polyelectrolyte nanogels as efficient protein carriers","volume":"620","author":"Zhou","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1660","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1016\/j.cclet.2022.01.086","article-title":"Microenvironment-responsive chemotherapeutic nanogels for enhancing tumor therapy via DNA damage and glutathione consumption","volume":"33","author":"Ye","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1665","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1670","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800337","article-title":"Nanoparticle-polymer synergies in nanocomposite hydrogels: from design to application","volume":"39","author":"Chen","year":"2018","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1675","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13346-015-0219-1","article-title":"Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach","volume":"5","author":"Tiwari","year":"2015","journal-title":"Drug Deliv. Translati. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1680","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073665","article-title":"Smart hydrogels for advanced drug delivery systems","volume":"23","author":"Bordbar-Khiabani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1685","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchem.1937","article-title":"Installing logic-gate responses to a variety of biological substances in supramolecular hydrogel-enzyme hybrids","volume":"6","author":"Ikeda","year":"2014","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1690","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","article-title":"Microfabricated microneedles: a novel approach to transdermal drug delivery","volume":"87","author":"Henry","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1695","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actbio.2020.12.004","article-title":"Microneedle-mediated transdermal drug delivery for treating diverse skin diseases","volume":"121","author":"Yang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1700","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1007\/s13346-021-01056-8","article-title":"Advances in microneedle-based transdermal delivery for drugs and peptides","volume":"12","author":"Aich","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1705","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1080\/10717544.2022.2122632","article-title":"Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model","volume":"29","author":"Liu","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1710","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1080\/03639045.2022.2027959","article-title":"Fabrication and characterization of dissolving microneedles for transdermal drug delivery of allopurinol","volume":"47","author":"Chen","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1715","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081736","article-title":"Promising strategies for transdermal delivery of arthritis drugs: microneedle systems","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1720","doi-asserted-by":"crossref","first-page":"119673","DOI":"10.1016\/j.ijpharm.2020.119673","article-title":"Current trends in polymer microneedle for transdermal drug delivery","volume":"587","author":"Ahmed Saeed Al-Japairai","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1725","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.cclet.2021.05.043","article-title":"Current development in wearable glucose meters","volume":"32","author":"Chen","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1730","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","article-title":"Dissolving microneedles: applications and growing therapeutic potential","volume":"348","author":"Sartawi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1735","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1039\/D2BM01836E","article-title":"Transdermal delivery of allopurinol to acute hyperuricemic mice via polymer microneedles for the regulation of serum uric acid levels","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1740","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s13346-022-01182-x","article-title":"Soluplus(\u00ae) polymeric nanomicelles improve solubility of BCS-class II drugs","volume":"12","author":"Pignatello","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1745","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/10837450.2020.1753770","article-title":"Mixed micelles of TPGS and Soluplus(\u00ae) for co-delivery of paclitaxel and fenretinide: in vitro and in vivo anticancer study","volume":"25","author":"Wang","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1750","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1208\/s12249-013-9971-z","article-title":"Plasticizer effects on physical-mechanical properties of solvent cast Soluplus\u00ae films","volume":"14","author":"Lim","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1755","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1039\/D2BM01068B","article-title":"Soluplus\u00ae-based dissolving microarray patches loaded with colchicine: towards a minimally invasive treatment and management of gout","volume":"10","author":"Anjani","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1760","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113919","article-title":"Microneedle-mediated vaccination: innovation and translation","volume":"179","author":"Sheng","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1765","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1166\/jbn.2019.2752","article-title":"Uricase and horseradish peroxidase hybrid CaHPO\u2084 nanoflower integrated with transcutaneous patches for treatment of hyperuricemia","volume":"15","author":"Hao","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1770","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.107827","article-title":"Carrier-free supramolecular nanomedicines assembled by small-molecule therapeutics for cancer treatment","volume":"34","author":"Zuo","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1775","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1039\/D2BM01937J","article-title":"A mechanically tough and ultra-swellable microneedle for acute gout arthritis","volume":"11","author":"Jiang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1780","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121669","article-title":"Process optimization of Ca(2+) cross-linked alginate-based swellable microneedles for enhanced transdermal permeability: more applicable to acidic drugs","volume":"618","author":"Zhou","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1785","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121612","article-title":"Preparation, characterisation and comparison of glabridin-loaded hydrogel-forming microneedles by chemical and physical cross-linking","volume":"617","author":"Pan","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1790","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1016\/j.cclet.2022.02.047","article-title":"Rational design of nanocarriers for mitochondria-targeted drug delivery","volume":"33","author":"Huang","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1795","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.apsb.2018.01.007","article-title":"Mesoporous silica nanoparticles for drug and gene delivery","volume":"8","author":"Zhou","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1800","first-page":"32","article-title":"Inorganic nano-carriers based smart drug delivery systems for tumor therapy","volume":"1","author":"Shi","year":"2020","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1805","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040167","article-title":"Porous inorganic carriers based on silica, calcium carbonate and calcium phosphate for controlled\/modulated drug delivery: fresh outlook and future perspectives","volume":"10","author":"Trofimov","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1810","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103386","article-title":"Inorganic nanoparticle-based advanced cancer therapies: promising combination strategies","volume":"27","author":"Amaldoss","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1815","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1820","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1039\/D2CS00352J","article-title":"Bioactive inorganic nanomaterials for cancer theranostics","volume":"52","author":"Pei","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1825","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bios.2019.04.013","article-title":"Direct quantification of cancerous exosomes via surface plasmon resonance with dual gold nanoparticle-assisted signal amplification","volume":"135","author":"Wang","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1830","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181971","article-title":"Seedless gold nanostars with seed-like advantages for biosensing applications","volume":"6","author":"Phiri","year":"2019","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1835","first-page":"1474","article-title":"Functionalized gold nanoparticles: synthesis, properties and biomedical applications","volume":"20","author":"Fan","year":"2020","journal-title":"Chem. Reco. (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1840","doi-asserted-by":"crossref","first-page":"13342","DOI":"10.1021\/acs.chemrev.1c00422","article-title":"Gold nanorods: the most versatile plasmonic nanoparticles","volume":"121","author":"Zheng","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1845","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03342620","article-title":"An European open multicenter trial with auranofin in rheumatoid-arthritis","volume":"3","author":"Raeman","year":"1984","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1850","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.110642","article-title":"Folic acid-modified lysozyme protected gold nanoclusters as an effective anti-inflammatory drug for rapid relief of gout flares in hyperuricemic rats","volume":"217","author":"Sun","year":"2022","journal-title":"Mater. Des."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1855","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1039\/C7AN01680H","article-title":"Functionalized gold nanoparticle-enhanced competitive assay for sensitive small-molecule metabolite detection using surface plasmon resonance","volume":"143","author":"Cao","year":"2017","journal-title":"Analyst"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1860","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800090","article-title":"Reversible shrinkage of DNA-functionalized gold nanoparticle assemblies revealed by surface plasmon resonance","volume":"13","author":"Wang","year":"2018","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1865","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5101\/nbe.v6i4.p104-110","article-title":"De-crystallization of uric acid crystals in synovial fluid using gold colloids and microwave heating","volume":"6","author":"Kioko","year":"2014","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1870","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.saa.2017.01.056","article-title":"Synthesis, characterization and xanthine oxidase inhibition of Cu(II)-chrysin complex","volume":"178","author":"Lin","year":"2017","journal-title":"Spectrochim. Acta Part A-Mol. Biomol. Spectroscopy"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1875","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jtemb.2018.04.019","article-title":"Compounds containing trace element copper or zinc exhibit as potent hyperuricemia inhibitors via xanthine oxidase inactivation","volume":"49","author":"Li","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1880","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-4838(00)00207-7","article-title":"Interaction of Cu2+ ion with milk xanthine oxidase","volume":"1544","author":"Sau","year":"2001","journal-title":"Biochim. Biophys. Acta-Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1885","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12011-019-01734-2","article-title":"Inhibition of hyperuricemia and gouty arthritis in BALB\/c mice using copper oxide nanoparticles","volume":"193","author":"Kiyani","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1890","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12011-021-02615-3","article-title":"Evaluation of antioxidant activity and histopathological changes occurred by the oral ingestion of CuO nanoparticles in monosodium urate crystal-induced hyperuricemic BALB\/c mice","volume":"200","author":"Kiyani","year":"2022","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1895","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jtemb.2014.07.019","article-title":"Zinc: an antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging","volume":"28","author":"Prasad","year":"2014","journal-title":"J. Trace Elements Med. Biolo. Soc. Min. Trace Elements (GMS)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1900","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008637","article-title":"Association between low dietary zinc and hyperuricaemia in middle-aged and older males in China: a cross-sectional study","volume":"5","author":"Xie","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1905","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jtemb.2019.08.012","article-title":"Antioxidant and anti-gout effects of orally administered zinc oxide nanoparticles in gouty mice","volume":"56","author":"Kiyani","year":"2019","journal-title":"J. Trace Elements Med. Biolo. Soc. Min. Trace Elements (GMS)"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1910","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10937404.2016.1168762","article-title":"Gold nanoparticles: a critical review of therapeutic applications and toxicological aspects","volume":"19","author":"Hornos Carneiro","year":"2016","journal-title":"J. Toxicol. Environ. Health-Part B-Critical Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1915","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1920","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1002\/anie.200460649","article-title":"Nanozymes: gold-nanoparticle-based transphosphorylation catalysts","volume":"43","author":"Manea","year":"2004","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1925","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101269","article-title":"Nanozymes: a clear definition with fuzzy edges","volume":"40","author":"Wei","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1930","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1039\/c0cp01759k","article-title":"Nano-sized platinum as a mimic of uricase catalyzing the oxidative degradation of uric acid","volume":"13","author":"Dong","year":"2011","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1935","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1039\/C8NJ01902A","article-title":"Unique dual responsive activity of a platinum nanozyme stabilized by a green solvent: deep eutectic solvents","volume":"42","author":"Devi","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1940","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/acs.nanolett.1c04454","article-title":"Self-cascade uricase\/catalase mimics alleviate acute gout","volume":"22","author":"Lin","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1945","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcis.2021.05.025","article-title":"Arginine-rich peptide\/platinum hybrid colloid nanoparticle cluster: a single nanozyme mimicking multi-enzymatic cascade systems in peroxisome","volume":"600","author":"Liu","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1950","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/prot.340190105","article-title":"The role of arginine 143 in the electrostatics and mechanism of Cu,Zn superoxide dismutase: computational and experimental evaluation by mutational analysis","volume":"19","author":"Fisher","year":"1994","journal-title":"Proteins"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1955","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1021\/acs.langmuir.2c00070","article-title":"Surface science of nanozymes and defining a nanozyme unit","volume":"38","author":"Zandieh","year":"2022","journal-title":"Langmuir: ACS J. Surf. Colloids"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1960","doi-asserted-by":"crossref","first-page":"15645","DOI":"10.1021\/acsnano.1c07520","article-title":"Nanozyme catalytic turnover and self-limited reactions","volume":"15","author":"Zandieh","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1965","doi-asserted-by":"crossref","first-page":"19059","DOI":"10.1021\/acsami.8b04559","article-title":"Highly controlled diffusion drug release from ureasil-poly(ethylene oxide)-Na+-montmorillonite hybrid hydrogel nanocomposites","volume":"10","author":"Jesus","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1970","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/IJN.S353349","article-title":"How advancing are mesoporous silica nanoparticles? A comprehensive review of the literature","volume":"17","author":"Porrang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1975","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202200573","article-title":"Silica-based nanoparticles for enzyme immobilization and delivery","volume":"17","author":"Zhao","year":"2022","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1980","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.1002\/adfm.201602932","article-title":"Artificial metalloenzyme-based enzyme replacement therapy for the treatment of hyperuricemia","volume":"26","author":"Liu","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1985","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2011.07.001","article-title":"Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy","volume":"79","author":"Hu","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb1990","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.7150\/thno.40414","article-title":"Autophagy modulated by inorganic nanomaterials","volume":"10","author":"Guo","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.09.011_bb1995","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114022","article-title":"Mechanisms of immune response to inorganic nanoparticles and their degradation products","volume":"180","author":"Mohammapdour","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2000","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1039\/D0CS00461H","article-title":"Inorganic nanomaterials with rapid clearance for biomedical applications","volume":"50","author":"Wang","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.talanta.2016.01.018","article-title":"Label-free and selective sensing of uric acid with gold nanoclusters as optical probe","volume":"152","author":"Wang","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijbiomac.2022.02.137","article-title":"Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: a comprehensive review","volume":"206","author":"Sargazi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2015","first-page":"8200","article-title":"A portable detection kit using Au nanoparticles modified carbon paste electrode for screening uricemia patients","volume":"16","author":"Rajan","year":"2016","journal-title":"IEEE Sensors J."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2020","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2021.130674","article-title":"A conducting polymer PEDOT:PSS hydrogel based wearable sensor for accurate uric acid detection in human sweat","volume":"348","author":"Xu","year":"2021","journal-title":"Sensors Actuat. B-Chem."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2025","doi-asserted-by":"crossref","DOI":"10.1007\/s10544-020-00511-6","article-title":"Wireless, battery-free and wearable device for electrically controlled drug delivery: sodium salicylate released from bilayer polypyrrole by near-field communication on smartphone","volume":"22","author":"Liu","year":"2020","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113530","article-title":"Luminescent wearable biosensors based on gold nanocluster networks for \"turn-on\" detection of Uric acid, glucose and alcohol in sweat","volume":"192","author":"Zhou","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00604-021-04971-2","article-title":"A highly sensitive dual-read assay using nitrogen-doped carbon dots for the quantitation of uric acid in human serum and urine samples","volume":"188","author":"Li","year":"2021","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2040","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339911","article-title":"Wearable transdermal colorimetric microneedle patch for Uric acid monitoring based on peroxidase-like polypyrrole nanoparticles","volume":"1212","author":"Zhang","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2045","first-page":"381","article-title":"A brief history of synthetic biology. Nature reviews","volume":"12","author":"Cameron","year":"2014","journal-title":"Microbiology"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41573-021-00285-3","article-title":"Engineering living therapeutics with synthetic biology","volume":"20","author":"Cubillos-Ruiz","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.ade0156","article-title":"Multidimensional control of therapeutic human cell function with synthetic gene circuits","volume":"378","author":"Li","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nbt.1617","article-title":"Self-sufficient control of urate homeostasis in mice by a synthetic circuit","volume":"28","author":"Kemmer","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2022.05.034","article-title":"The structure of Deinococcus radiodurans transcriptional regulator HucR retold with the urate bound","volume":"615","author":"Rho","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijbiomac.2021.01.163","article-title":"Expression, localization and metabolic function of \"resurrected\" human urate oxidase in human hepatocytes","volume":"175","author":"Duan","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2075","doi-asserted-by":"crossref","first-page":"15705","DOI":"10.1021\/acsnano.2c06104","article-title":"Artificial cells: past, present and future","volume":"16","author":"Jiang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2080","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1002\/chem.201002782","article-title":"Enzymatic cascade reactions inside polymeric nanocontainers: a means to combat oxidative stress","volume":"17","author":"Tanner","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2085","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1021\/acs.biomac.8b01019","article-title":"Nanoscale enzymatic compartments in tandem support cascade reactions in vitro","volume":"19","author":"Belluati","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2090","article-title":"Nanozyme-based artificial organelles: an emerging direction for artificial organelles","volume":"18","author":"Zhang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2095","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007130","article-title":"A nanozyme-based artificial peroxisome ameliorates hyperuricemia and ischemic stroke","volume":"31","author":"Xi","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.09.006","article-title":"Novel lipidic and bienzymatic nanosomes for efficient delivery and enhanced bioactivity of catalase","volume":"532","author":"Li","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2105","doi-asserted-by":"crossref","first-page":"20136","DOI":"10.1038\/srep20136","article-title":"Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changes","volume":"7","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/10717544.2018.1559258","article-title":"Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome","volume":"26","author":"Zhang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","article-title":"Niosomes: novel sustained release nonionic stable vesicular systems--an overview","volume":"183-184","author":"Mahale","year":"2012","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","article-title":"Niosomes from 80s to present: the state of the art","volume":"205","author":"Marianecci","year":"2014","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2125","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1021\/acs.nanolett.0c01654","article-title":"Multimodal enzyme delivery and therapy enabled by cell membrane-coated metal-organic framework nanoparticles","volume":"20","author":"Zhuang","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12951-020-00675-6","article-title":"Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis","volume":"18","author":"Yan","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.apsb.2014.09.001","article-title":"Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations","volume":"4","author":"Kollipara","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2145","article-title":"Spatial confined synergistic enzymes with enhanced uricolytic performance and reduced toxicity for effective gout treatment","author":"Zhang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2150","doi-asserted-by":"crossref","first-page":"15342","DOI":"10.1002\/anie.201907670","article-title":"Stimuli-responsive biomolecule-based hydrogels and their applications","volume":"59","author":"V\u00e1zquez-Gonz\u00e1lez","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2155","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001341","article-title":"Recent advances in injectable hydrogels for controlled and local drug delivery","volume":"10","author":"Rizzo","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2160","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1039\/D0TB02877K","article-title":"Recent advances in thermo-sensitive hydrogels for drug delivery","volume":"9","author":"Yu","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2165","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03719","article-title":"Commercial hydrogels for biomedical applications","volume":"6","author":"Aswathy","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jconrel.2022.04.043","article-title":"Dissolvable polymer microneedles for drug delivery and diagnostics","volume":"347","author":"Ali","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2175","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100577","article-title":"Soft wearable healthcare materials and devices","volume":"10","author":"Lyu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.09.011_bb2180","article-title":"Carbon-based flexible devices for comprehensive health monitoring","volume":"7","author":"Wang","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2023.09.011_bb2185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206563119","article-title":"Stimuli-responsive vesicles as distributed artificial organelles for bacterial activation","volume":"119","author":"Gispert","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:55:15Z","timestamp":1759164915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923005977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":437,"alternative-id":["S0168365923005977"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gout therapeutics and drug delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}